Impact of Fluticasone and Salmeterol on Airway Dendritic Cells (DCs) in Smokers
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Airway dendritic cells (DCs) play a key role in smoke-related lung diseases. In this study,
the researchers investigate the effects of fluticasone and salmeterol on human airway DCs in
smokers. The researchers hypothesize that fluticasone and salmeterol impact on the number and
the characteristics of airway DCs in smokers.
Phase:
Phase 1
Details
Lead Sponsor:
University of Rostock
Collaborator:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Salmeterol Xinafoate Xhance